Sarcopenia assessed by skeletal muscle mass volume is a prognostic factor for oncological outcomes of rectal cancer patients undergoing neoadjuvant chemoradiotherapy followed by surgery

Kazumasa Horie(Kobe University), Yoshihiro Kakeji(Kobe University), Kimihiro Yamashita(Teikyo University), Naoki Urakawa(Kobe University), Takeru Matsuda(RIKEN Center for Brain Science), Hiroshi Hasegawa(Shibaura Institute of Technology), Shingo Kanaji(Kobe University), Masako Utsumi(Kobe University), Taro Oshikiri(Kobe University)
European Journal of Surgical Oncology
October 27, 2021
Cited by 26


Related Papers